You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 2月10日港股收盤

根據uSMART輿情監測數據,10日港股交易時段,市場關注指數最高的5只股票是百勝中國-S、藥明生物、融創中國、保利協鑫能源、中國恆大。

2月10日—港股關注排行TOP5

輿情變化榜單

百勝中國-S

個股K線圖

關注度第一爲百勝中國-S,該股今日收盤上漲8.52%,報於377.00港元。近5個交易日累計上漲3.40%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

大和:上調百勝中國-S評級至“買入” 目標價降14.2%至467.4港元

高盛維持百勝中國-S買入評級 目標價續看513港元

藥明生物

個股K線圖

關注度第二爲藥明生物,該股今日收盤下跌5.36%,報於58.30港元。近5個交易日累計下跌23.24%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

大和降藥明生物至跑贏大市評級 料其美國業務仍存不確定性

恆生指數午盤收跌0.48%報24710點 藥明生物跌7.39%

融創中國

個股K線圖

關注度第三爲融創中國,該股今日收盤上漲10.97%,報於10.72港元。近5個交易日累計上漲12.02%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

融創中國拉昇9% 宣佈完成組織架構調整,機構看好民企地產接力估值修復

恆指全日收報24,924點 升94點; 恆生科技指數全日收報5,666點 升31點 融創中國升逾10% 中國海外發展、交行、中行、神華、一太創新高 成交暢旺

保利協鑫能源

個股K線圖

關注度第四爲保利協鑫能源,該股今日收盤上漲2.81%,報於2.56港元。近5個交易日累計上漲9.40%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

保利協鑫能源高開8.43% 公司啓動中國境內證券交易所上市的可行性研究

恆指漲0.89% 保利協鑫能源高開逾8% 啓動可能於中國境內證券交易所上市的可行性研究

中國恆大

個股K線圖

關注度第五爲中國恆大,該股今日收盤上漲5.39%,報於1.76港元。近5個交易日累計上漲6.02%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

快訊:中國恆大漲近6%領漲恆大系 許家印透露恆大目前預售監管資金500多億

“恆大系”集體走高,中國恆大一度漲超7%!許家印新年開工講話曝光

此外,監測期內有1只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

2月10日—港股輿情轉折預警

輿情變化榜單

藥明生物

個股K線圖

藥明生物輿情扭轉指數達99,目前輿情方向爲利空,表明公司出現了被投資者視作較大利空的消息。

其中較被市場關注的消息有:

大和降藥明生物至跑贏大市評級 料其美國業務仍存不確定性

恆生指數午盤收跌0.48%報24710點 藥明生物跌7.39%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account